Next Article in Journal
Efficiency Enhancement of Perovskite Solar Cells with Plasmonic Nanoparticles: A Simulation Study
Previous Article in Journal
ZnO/ZnAl2O4 Nanocomposite with 3D Sphere-Like Hierarchical Structure for Photocatalytic Reduction of Aqueous Cr(VI)
Previous Article in Special Issue
Nanoscale and Macroscale Scaffolds with Controlled-Release Polymeric Systems for Dental Craniomaxillofacial Tissue Engineering
Open AccessArticle

Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications

1
Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan 333, Taiwan
2
Craniofacial Research Center, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan 333, Taiwan
3
Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital at Keelung, Chang Gung University, College of Medicine, Keelung 204, Taiwan
*
Author to whom correspondence should be addressed.
Denotes equal contribution.
Materials 2018, 11(9), 1625; https://doi.org/10.3390/ma11091625
Received: 18 July 2018 / Revised: 26 August 2018 / Accepted: 3 September 2018 / Published: 5 September 2018
(This article belongs to the Special Issue Polymeric Materials for Medical Applications)
In this study, dissolving polymeric microneedle (MN) patches composed of gelatin and sodium carboxymethyl cellulose (CMC) were used to localize insulin. Their in vitro skin insertion capabilities were determined using tissue-marking dye to stain the skin after patches removal. Scanning electron microscopy (SEM) was used to determine changes in the MNs over time, and optical coherence tomography (OCT) was used to monitor their real-time penetration depth. Confocal microscopy images revealed that rhodamine 6G gradually diffuses from the puncture sites to deeper dermal tissue. Using an in vivo imaging system (IVIS), skin areas that received FITC-insulin-loaded MNs were found to present strong fluorescent signals that greatly decreased 1 h after application. Results show that dissolving MNs rapidly release FITC-insulin, and it then gradually diffuses into the skin. This study verifies that using a gelatin/CMC MN patch for insulin delivery achieves satisfactory relative bioavailability compared to a traditional hypodermic injection and can be a promising delivery device for poorly permeable protein drugs such as those used to treat diabetes. Insertion tests on human cadaveric skin demonstrate that dissolving MNs could serve as efficient devices for transdermal drug delivery in clinical practice and that the volar aspect of forearm skin is the ideal location for their applications. View Full-Text
Keywords: microneedle; polymer; transdermal; insulin; diabetes mellitus microneedle; polymer; transdermal; insulin; diabetes mellitus
Show Figures

Figure 1

MDPI and ACS Style

Chen, C.-H.; Shyu, V.B.-H.; Chen, C.-T. Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications. Materials 2018, 11, 1625.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop